Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia

Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, is increasingly used in obese patients with type 2 diabetes mellitus (T2DM) in doses of up to 3.0 mg/day because of its attractive pharmacological profile. It is currently not known how to proceed with this medication during fasting for surgery....

Descripción completa

Detalles Bibliográficos
Autores principales: Koot, Rosalie, van Borren, Marcel, de Boer, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346799/
https://www.ncbi.nlm.nih.gov/pubmed/30755910
http://dx.doi.org/10.12890/2017_000712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346799/
https://www.ncbi.nlm.nih.gov/pubmed/30755910
http://dx.doi.org/10.12890/2017_000712

Ejemplares similares